HUTCHMED Sets 30 July Board Meeting to Approve 2026 Interim Results; Webcast Details Announced

Bulletin Express

06/30

HUTCHMED (China) Limited has scheduled its board meeting for 30 July 2026 to approve and publish interim results for the six months ended 30 June 2026. The announcement will be released at 7:00 p.m. Hong Kong Time on the same day.

Management will host two live webcasts to discuss the results: an English session with Q&A at 8:00 p.m. on 30 July 2026 and a Putonghua session at 8:30 a.m. on 31 July 2026. Both events can be accessed through the company’s website (www.hutch-med.com/event/), where presentation materials will be available for download shortly before the broadcasts, and replays will be posted afterward.

The board is chaired by Non-executive Director Dr Dan Eldar. Executive leadership includes Chief Executive Officer and Chief Scientific Officer Dr Weiguo Su and Acting Chief Executive Officer and Chief Financial Officer Johnny Cheng Chig Fung. The company secretary is Non-executive Director Edith Shih.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1186080921"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1186080921\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1186080921?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-30 16:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186080921","market":"hk","top_or_hot":-1,"title":"HUTCHMED Sets 30 July Board Meeting to Approve 2026 Interim Results; Webcast Details Announced","media":"Bulletin Express","content":"<p>HUTCHMED (China) Limited has scheduled its board meeting for 30 July 2026 to approve and publish interim results for the six months ended 30 June 2026. The announcement will be released at 7:00 p.m. Hong Kong Time on the same day.</p>\n<p>Management will host two live webcasts to discuss the results: an English session with Q&A at 8:00 p.m. on 30 July 2026 and a Putonghua session at 8:30 a.m. on 31 July 2026. Both events can be accessed through the company’s website (www.hutch-med.com/event/), where presentation materials will be available for download shortly before the broadcasts, and replays will be posted afterward.</p>\n<p>The board is chaired by Non-executive Director Dr Dan Eldar. Executive leadership includes Chief Executive Officer and Chief Scientific Officer Dr Weiguo Su and Acting Chief Executive Officer and Chief Financial Officer Johnny Cheng Chig Fung. The company secretary is Non-executive Director Edith Shih.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HUTCHMED Sets 30 July Board Meeting to Approve 2026 Interim Results; Webcast Details Announced</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHUTCHMED Sets 30 July Board Meeting to Approve 2026 Interim Results; Webcast Details Announced\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-30 16:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HUTCHMED (China) Limited has scheduled its board meeting for 30 July 2026 to approve and publish interim results for the six months ended 30 June 2026. The announcement will be released at 7:00 p.m. Hong Kong Time on the same day.</p>\n<p>Management will host two live webcasts to discuss the results: an English session with Q&A at 8:00 p.m. on 30 July 2026 and a Putonghua session at 8:30 a.m. on 31 July 2026. Both events can be accessed through the company’s website (www.hutch-med.com/event/), where presentation materials will be available for download shortly before the broadcasts, and replays will be posted afterward.</p>\n<p>The board is chaired by Non-executive Director Dr Dan Eldar. Executive leadership includes Chief Executive Officer and Chief Scientific Officer Dr Weiguo Su and Acting Chief Executive Officer and Chief Financial Officer Johnny Cheng Chig Fung. The company secretary is Non-executive Director Edith Shih.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00013","symbol_name":"和黄医药","start_time":0,"source_url":"","article_id":"1186080921","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186080921","pubTimestamp":1782809054,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"HUTCHMED (China) Limited has scheduled its board meeting for 30 July 2026 to approve and publish interim results for the six months ended 30 June 2026. The announcement will be released at 7:00 p.m....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00013":"和黄医药"},"translate_title":"和黄医药定于7月30日召开董事会批准2026年中期业绩；网络直播详情公布","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00013":1},"content_text":"HUTCHMED (China) Limited has scheduled its board meeting for 30 July 2026 to approve and publish interim results for the six months ended 30 June 2026. The announcement will be released at 7:00 p.m. Hong Kong Time on the same day.\nManagement will host two live webcasts to discuss the results: an English session with Q&A at 8:00 p.m. on 30 July 2026 and a Putonghua session at 8:30 a.m. on 31 July 2026. Both events can be accessed through the company’s website (www.hutch-med.com/event/), where presentation materials will be available for download shortly before the broadcasts, and replays will be posted afterward.\nThe board is chaired by Non-executive Director Dr Dan Eldar. Executive leadership includes Chief Executive Officer and Chief Scientific Officer Dr Weiguo Su and Acting Chief Executive Officer and Chief Financial Officer Johnny Cheng Chig Fung. The company secretary is Non-executive Director Edith Shih.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}